Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients "Flo 24"

Completed

Phase 1 Results N/A

Main Contacts

Name Phone E-mail
Flo 24 Steering Committee Study Chair

Other Locations

Name City State Country Status
Massachusetts General Hospital Boston Massachusetts United States Unknown_status_icon
University of Rochester Rochester New York United States Unknown_status_icon
UCLA Los Angeles California United States Unknown_status_icon
University of Alberta Edmonton Alberta Canada Unknown_status_icon
University of Calgary Calgary Alberta Canada Unknown_status_icon
University of Pittsburgh Pittsburgh Pennsylvania United States Unknown_status_icon
University of Essen Essen Germany Unknown_status_icon
University of North Carolina Chapel Hill North Carolina United States Unknown_status_icon
University of Erlangen Erlangen Germany Unknown_status_icon
CHUV Lausanne Lausanne Switzerland Unknown_status_icon